| Kalbitor |
125277 |
001 |
351(a) |
ecallantide |
Injection |
Subcutaneous |
10MG/ML |
Single-Dose Vial |
2009/12/01
|
Takeda Pharmaceuticals U.S.A., Inc. |
Rx |
Licensed |
N/A |
N/A |
| Agriflu |
125297 |
001 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intramuscular |
.05ML |
Syringe |
2009/11/27
|
Seqirus Inc. |
Disc |
Licensed |
|
N/A |
| Flulaval, Flulaval Quadrivalent |
125163 |
002 |
351(a) |
Influenza Vaccine |
Injection |
Intramuscular |
15UG/.5ML |
Multi-Dose Vial |
2009/11/10
|
ID Biomedical Corporation of Quebec |
Disc |
Licensed |
|
N/A |
| Arzerra |
125326 |
001 |
351(a) |
ofatumumab |
Injection |
Intravenous |
100MG/5ML |
Single-Dose Vial |
2009/10/26
|
Novartis Pharmaceuticals Corporation |
Disc |
Licensed |
N/A |
N/A |
| Cervarix |
125259 |
001 |
351(a) |
Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant |
Injection |
Intramuscular |
0.5ML |
Pre-Filled Syringe |
2009/10/16
|
GlaxoSmithKline Biologicals |
Disc |
Licensed |
|
N/A |
| Berinert |
125287 |
001 |
351(a) |
C1 Esterase Inhibitor (Human) |
For Injection |
Intravenous |
500U |
Single-Dose Vial |
2009/10/09
|
CSL Behring GmbH |
Rx |
Licensed |
|
N/A |
| Privigen |
125201 |
004 |
351(a) |
Immune Globulin Intravenous (Human), 10% Liquid |
Injection |
Intravenous |
2.5G |
Single-Dose Vial |
2009/10/02
|
CSL Behring AG |
Rx |
Licensed |
|
N/A |
| Stelara |
125261 |
001 |
351(a) |
ustekinumab |
Injection |
Subcutaneous |
45MG/0.5ML |
Single-Dose Vial |
2009/09/25
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Stelara |
125261 |
002 |
351(a) |
ustekinumab |
Injection |
Subcutaneous |
90MG/ML |
Single-Dose Vial |
2009/09/25
|
Janssen Biotech, Inc. |
Disc |
Licensed |
N/A |
N/A |
| Evithrom |
125247 |
004 |
351(a) |
Thrombin, Topical (Human) |
For Injection |
Topical |
1600-2400IU/ML |
Single-dose vial |
2009/09/17
|
Omrix Biopharmaceuticals Ltd |
Rx |
Licensed |
|
N/A |
| Gammaplex |
125329 |
001 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
10G/200ML |
Single-Dose Vial |
2009/09/17
|
Bio Products Laboratory Limited |
Disc |
Licensed |
|
N/A |
| Gammaplex |
125329 |
002 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
2.5G/50ML |
Single-Dose Vial |
2009/09/17
|
Bio Products Laboratory Limited |
Disc |
Licensed |
|
N/A |
| Gammaplex |
125329 |
003 |
351(a) |
Immune Globulin Intravenous (Human) |
Injection |
Intravenous |
5G/100ML |
Single-Dose Vial |
2009/09/17
|
Bio Products Laboratory Limited |
Disc |
Licensed |
|
N/A |
| Zenpep |
022210 |
001 |
351(a) |
pancrelipase |
Capsule, Delayed Release |
Oral |
5,000USP UNITS; 17,000USP UNITS; 24,000USP UNITS |
|
2009/08/27
|
Zenpep, LLC |
Rx |
Licensed |
N/A |
N/A |
| Zenpep |
022210 |
002 |
351(a) |
pancrelipase |
Capsule, Delayed Release |
Oral |
10,000USP UNITS; 32,000USP UNITS; 42,000USP UNITS |
|
2009/08/27
|
Zenpep, LLC |
Rx |
Licensed |
N/A |
N/A |
| Zenpep |
022210 |
003 |
351(a) |
pancrelipase |
Capsule, Delayed Release |
Oral |
15,000USP UNITS; 47,000USP UNITS; 63,000USP UNITS |
|
2009/08/27
|
Zenpep, LLC |
Rx |
Licensed |
N/A |
N/A |
| Zenpep |
022210 |
004 |
351(a) |
pancrelipase |
Capsule, Delayed Release |
Oral |
20,000USP UNITS; 63,000USP UNITS; 84,000USP UNITS |
|
2009/08/27
|
Zenpep, LLC |
Rx |
Licensed |
N/A |
N/A |
| Hiberix |
125347 |
001 |
351(a) |
Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) |
For Injection |
Intramuscular |
10UG/25UG |
Single-Dose Vial |
2009/08/19
|
GlaxoSmithKline Biologicals |
Rx |
Licensed |
|
N/A |
| Extavia |
125290 |
001 |
351(a) |
interferon beta-1b |
For Injection |
Subcutaneous |
0.3MG |
Single-Dose Vial |
2009/08/14
|
Novartis Pharmaceuticals Corporation |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Helixate Fs, Kogenate, Kogenate Fs |
103332 |
005 |
351(a) |
Antihemophilic Factor (Recombinant) |
For Injection |
Intravenous |
3000IU |
Single-Dose Vial |
2009/07/31
|
Bayer HealthCare LLC |
Disc |
Licensed |
|
N/A |